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Abstract
Background: Depletion of the circulating actin-binding protein, plasma gelsolin (pGSN) has been described in critically ill
surgical patients. We hypothesized that the extent of pGSN reduction might correlate with different outcome of burn
patients. The study was performed to evaluate the prognostic implications of pGSN levels on the development of multiple
organ dysfunction syndrome (MODS) and fatal outcome in a group of severely burn patients.
Methods and Findings: 95 patients were included, and they were divided into three groups with different burn area: group
I (n=33), group II (n=32) and group III (n=30). According to whether there was development of MODS or not, patients
were divided into MODS group (n=28) and none-MODS group (n=67); then the patients with MODS were further divided
into non-survivor group (n=17) and survivor group (n=11). The peripheral blood samples were collected on postburn days
(PBD) 1, 3, 7, 14, and 21. The levels of pGSN were determined and T cells were procured from the blood. The contents of
cytokines (IL-2, IL-4 and IFN-c) released by T cells were also measured. The related factors of prognosis were analyzed by
using multivariate logistic regression analysis. The results showed that pGSN concentrations, as well as the levels of IL-2 and
IFN-c, decreased markedly on PBD 1–21, whereas, the levels of IL-4 increased markedly in all burn groups as compared with
normal controls (P,0.05 or P,0.01), and there were obviously differences between group I and group III (P,0.05 or
P,0.01). The similar results were found in MODS patients and the non-survivor group as compared with those without
MODS and the survival group on days 3–21 postburn (P,0.05 or P,0.01). Moreover, as the pGSN levels decreased, the
incidence of septic complication as well as MODS remarkably increased.
Conclusions: pGSN levels appear to be an early prognostic marker in patients suffering from major burns.
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Introduction
Burn injury is one of the most common and devastating forms of
trauma. Patients with severe burns require immediate specialized
care in order to minimize morbidity and mortality. It has been
demonstrated that a large thermal injury induces a state of
immunosuppression that predisposes the patient to infectious
complications [1]. It causes immune dysfunction involving both
pro- and anti-inflammatory responses. The hallmark of the latter is
a decrease in monocyte human leukocyte antigen-DR (HLA-DR)
expression [2]. Meanwhile, enhanced microvascular permeability
is also a fundamental component of the systemic inflammation
that accompanies acute burn injury. Because actin is one of the
most abundant proteins within cells (5–20% cell protein by weight
for nonmuscle cells and 25% for muscle) [3], the amount of actin
filaments released into the extracellular compartment during burn
injury could conceivably be quite large. Previous studies showed
that the infusion of actin monomers into rats caused pulmonary
endothelial and vascular dysfunction [4]. Actin filaments could
injure the microvasculature by either a direct effect on the vascular
endothelium [4,5] or by activating platelets [6] with resulting
platelet aggregation, microvascular thrombosis, and perhaps the
release of proinflammatory mediators such as thromboxane and
lysophosphatidic acid (LPA).
Gelsolin, a protein of 82 to 84 kDa, is a member of gelsolin
protein superfamily, which exists in a cytoplasmic as well as an
excreted plasma isoform, and contains six homologous repeats
termed gelsolin-like (G) domains [7–9]. Plasma gelsolin (pGSN) is
the principal circulating protein which is able to sever and
scavenge circulating filamentous actin [10–12]. In animal models,
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counteract the pathophysiological consequences of actin release
during trauma, shock and infection [13–16]. Further studies have
revealed that critical extent of pGSN depletion in patients
subjected to trauma, burns, major surgery or hematopoietic stem
cell transplantation correlates with poor clinical outcome [17–
19]. In addition, the finding that pGSN binds inflammatory
mediators, including platelet activating factor as well as lysopho-
sphatidic acid, suggests that its physiological function may be to
localize inflammation and blunt its systemic effects, and that
extensive pGSN depletion due to actin exposure following acute
insults allows inflammatory mediators to cause widespread tissue
damage [20]. Soon after traumatic injury, plasma concentrations
of gelsolin are significantly reduced compared with those in
healthy individuals [19]. Admission pGSN levels in patients with
a variety of critical illness were associated with the development
of multiple organ dysfunction syndrome (MODS) and septic
shock [19,21]. The main pathological conditions and the
mechanisms which gelsolin involved in have been listed in
Table 1.
Numerous studies show that an increased burn size leads to
higher mortality in burn patients [22]. It was also implicated that
the extent of burn size might be associated with the development
of MODS [23]. The stress response to burn injury is similar to that
of severe trauma or critical illness but differs in its severity and
duration. The inflammatory response is triggered immediately
after thermal injury and persists for almost 5 weeks postburn [24].
Superimposed severe infection can result in the disorder of one or
more aspects of function of the host immune system and further
induce suppression of immune function of T lymphocyte with
shifting of Th1 (IL-2, IFN-c) to Th2 (IL-4) following burn injury
[22,24]. However, little is known about the changes in pGSN level
during the course of burn or its relationship with the extent of
burns and the prognosis of the patient with severe burn. The aim
of the study was to investigate the time course of pGSN levels in a
relatively large sample involving 95 patients with severe burn and
to determine whether the levels of pGSN could predict the
immune states or outcome of patients.
Methods
Patient population and demography
95 patients who were consecutively admitted to our burn
departments with total body surface area (TBSA) larger than 30%
were included in the present study over a time period of 18
months. Patients were successfully resuscitated using colloid and
lactated Ringer’s solution. Within 96 hours of admission most
patients underwent burn wound excision for full-thickness burn,
and the excision wounds were seeded with granulated autologous
skin, and totally covered with allograft. Five to ten days after
healing of the donor area, the remaining wounds, if there was any,
were totally covered with autograft skin.
The thermally injured patients were stratified into three groups
according to burn size: 30%–49% TBSA burns (group I, n=33),
50%–69% TBSA burns (group II, n=32), and .70% TBSA
burns (group III, n=30). Demographic, laboratory, and clinical
data were collected, and the Sequential Organ Failure Assess-
ment (SOFA) score [25] was calculated, on admission and every
24 hours until postburn day (PBD) 21. In the calculation of the
score, the worst values for each parameter in the 24-hour period
were used. In sedated patients, the assumed Glasgow Coma Score
Scale was used to evaluate the neurological status. The total
SOFA was calculated as the sum of all daily SOFA scores for
each patient. The mean score was defined as the ratio of total
score to the length of stay (21 days) in the burn department.
Failure of vital systems, such as respiratory system, circulatory
system, renal and other systems, were recorded. Diagnosis of
sepsis was confirmed by positive blood culture and the pathogen
was identified during hospitalization or at autopsy, in combina-
tion with leucocytosis or leucopenia, hyperthermia or hypother-
mia, and tachycardia [26]. According to whether there was
development of MODS or not, patients were divided into MODS
group (n=28) and non-MODS group (n=67) based on the
SOFA score and the criteria for definition of MODS [27]. Then
the patients with MODS were further divided into non-survivor
group (n=17) and survivor group (n=11). 25 healthy volunteers
from the lab staff served as normal controls (17 men and 8
Table 1. Gelsolin and diseases.
Related diseases Main mechanisms linked to gelsolin
Acute inflammation Gelsolin null mice respond more slowly to an induced inflammatory stimulus such as intraperitoneal thioglycollate instillation
(Witke et al., 1995).The slower kinetics of leukocyte accumulation in gelsolin null mice were similar to those observed in P-
selectin knockout mice (Mayadas et al., 1993) and most likely due to an impaired emigration of leukocytes from blood vessels
(Witke et al., 1995). The blunted inflammatory response in gelsolin null mice is restricted to the early acute phase which
suggests that gelsolin could represent a potential target for anti-inflammatory therapy (Witke et al., 1995).
Amyloidosis One type of familial amyloidosis first identified in the Finnish population is caused by deposition of gelsolin (Maury et al.,
2000; Maury et al., 2001). Plasma gelsolin isolated from homozygous Finnish type familial amyloidosis (FAF) patients lacks
both, actin severing and nucleating activities (Weeds et al., 1993). In contrast, cytoplasmic gelsolin is not cleaved in these
patients and the cellular actin modulating function of intracellular gelsolin is not affected (Kangas et al., 1999).
Chronic rheumatoid arthritis (RA) Recent studies in the mouse as well as in patients have confirmed that gelsolin expression is lost in rheumatoid synovial
fibroblasts leading to severe alterations in cytoskeletal organization (Aidinis et al., 2005). Furthermore, induction of RA in
gelsolin null mice resulted in the exacerbation of the disease symptoms, suggesting that loss of gelsolin plays an important
role in the pathophysiology of the disease.
Crohn’s diseases Smooth muscle from Crohn’s patients change their phenotype from a contractile form to a migratory form that correlates
with an increased expression of gelsolin (Ehrlich et al., 2000).
Cancer Gelsolin expression is downregulated in 60–90% of tumors during carcinogenesis of breast, colon, stomach, bladder, prostate,
and lung (Asch et al., 1999; Kuzumaki et al., 1997; Tanaka et al., 1995; Dosaka-Akita et al., 1998; Prasad et al., 1997; Sagawa
et al., 2003). In these cancer types downregulation of gelsolin during tumor progression was observed and overexpression of
gelsolin reverted the transformed phenotype in cell culture and mouse models (Sagawa et al., 2003). However, in a subset of
breast tumors overexpressing the tyrosine kinase receptors erbB-2 and EGFR, gelsolin overexpression was described to
correlate with negative prognoses (Thor et al., 2001).
doi:10.1371/journal.pone.0025748.t001
Gelsolin and MODS after Burns
PLoS ONE | www.plosone.org 2 November 2011 | Volume 6 | Issue 11 | e25748women, with mean age of 28.666.2 years, range 21–45 years).
Whole blood samples (5 ml) were collected into EDTA-
containing tubes from patients on PBD 1, 3, 7, 14, and 21
(patients died within PBD 21 were excluded from the study).
After being centrifuged at 2,500 g for 5 minutes, plasma was
harvested and frozen at 280uC until analysis. The study was
reviewed and approved by the Institutional Review Board of the
Burns Institute, First Hospital Affiliated to the Chinese PLA
General Hospital, Beijing, China. Prior to the study, an informed
consent was signed by the patient or next of kin. All patients and
volunteers were of Chinese Han origin.
pGSN measurements by ELISA
pGSN levels were measured using an enzyme-linked immuno-
sorbent assay (ELISA), in accordance with the manufacturer’s
instructions (ELAab Science Co., Wuhan, China). The microtiter
plate provided in this kit has been pre-coated with an antibody
specific to GSN. Standards or samples were then added to the
appropriate microtiter plate wells with a biotin-conjugated
polyclonal antibody preparation specific for GSN. Next, avidin
conjugated to horseradish peroxidase (HRP) was added to each
microplate well and incubated. Then a TMB substrate solution
was added to each well. Only those wells that contain GSN, biotin-
conjugated antibody and enzyme-conjugated avidin would exhibit
a change in color. The enzyme-substrate reaction was terminated
by the addition of a sulphuric acid solution and the color change
was measured spectrophotometrically at a wavelength of 450 nm.
The concentration of GSN in the samples was then determined by
comparing the O.D. of the samples to the standard curve. No
significant cross-reactivity or interference was observed.
Isolation of peripheral blood T lymphocytes
Heparinised blood was diluted in Hanks’ balanced salt solution,
and Ficoll-Hypaque (Sigma Chemical Co., St. Louis, MO) was
used for isolation and preparation of peripheral blood lympho-
cytes. The isolated lymphocytes were washed twice with phosphate
buffered saline (PBS), centrifuged (500 g, 4 minutes), resuspended
in basal medium (unstimulated culture) RPMI-1640 (Gibco-BRL,
Gaithersburg, MD) containing 10% fetal calf serum (Seromed,
Berlin, Germany), 1% penicillin/streptomycin (Sigma Chemical
Co., St. Louis, MO), and 1% glutamine (ICN, Eschwege,
Germany). Then cell populations were counted under a light
microscope. Based on the different experimental demand, the
peripheral blood mononuclear cells (PBMC) suspension was
diluted with RPMI-1640 to 2610
6 cells/ml. Cells were treated
Table 2. Demographic and clinical characteristics of the patients.
Variable Overall Group I Group II Group III MODS
Non-
MODS Survivors
Non-
survivors
n 95 33 32 30 28 67 11 17
Gender, n (%)
Male 69 (72.6) 21 (63.6) 26 (81.3) 22 (73.3) 19 (67.9) 50 (74.6) 8 (72.7) 12 (70.6)
Female 26 (27.4) 12 (36.4) 6 (18.7) 8 (26.7) 9 (32.1) 17 (25.4) 3 (27.3) 5 (29.4)
Male/Female 2.7 1.8 4.3 2.8 2.1 2.9 2.7 2.4
Age (years) 34.865.7 36.367.2 29.967.6 35.567.8 37.168.9 32.365.2 36.4613.2 33.8610.5
Burn area (TBSA%)
Range 30–99 30–49 50–69 70–99 30–99 30–85 30–95 30–99
Mean area 55.36
8.2
37.56
6.8
58.26
12.9
**
83.56
17.7
&&
74.16
16.3
##
47.56
9.7
55.66
19.7
{{
78.26
25.6
IIIu area 34.566.8 15.463.5 34.166.5
** 61.3614.9
&& 53.3616.4
## 27.264.4 39.6615.2
{{ 59.2617.1
Length of stay (days) 59.5610.4 33.666.1 55.4611.8
** 72.5615.1
&& 65.6618.5
## 53.268.9 115.8637.3
{{ 31.2612.7
Operations (n) 5.661.2 3.860.9 5.861.9
** 8.262.4
&& 6.962.6
## 4.460.7 9.863.7
{{ 5.761.9
Inhalation injury,
n( % )
21
(22.1)
3
(9.1)
6
(18.8)
12
(40.0)
19
(67.9)
2
(3.0)
5
(45.5)
14
(82.4)
Ventilator,
n( % )
17 (17.9) 1 (3.0) 4 (12.5) 12 (40.0) 17 (60.7) 0 (0) 8 (72.7) 9 (52.9)
The results were presented as the mean 6 standard deviation or percentage. Tukey Test was used to evaluate significant differences between groups. TBSA, total body
surface area; IIIu area, third-degree burn area; MODS, multiple organ dysfunction syndrome.
Significant difference between Group II and Group I (
**P,0.01); Significant difference between Group II and Group III (
&&P,0.01); Significant difference between MODS
group versus Non- MODS group (
##P,0.01); Significant difference between survivors group compared with non-survivors group (
{{P,0.01).
doi:10.1371/journal.pone.0025748.t002
Figure 1. Time course of pGSN levels after burn injury. Time
course of pGSN levels after burn injury. Mean pGSN levels were
significantly decreased during PBD 1–21 compared with normal
controls (all P,0.01), and there was a significantly lower level of pGSN
on PBD 7 compared with other time points. **P,0.01, burn group vs.
normal group.
doi:10.1371/journal.pone.0025748.g001
Gelsolin and MODS after Burns
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humidified air, and the contents of cytokines [interleukin (IL)-2,
IL-4 and interferon (IFN)-c] released into supernatants were
determined.
Cytokine measurements by ELISA
IL-2, IL-4 and IFN-c levels were determined by ELISA, strictly
following the protocols provided by the manufacturer (Biosource,
Worcester, MA). The color reaction was also terminated by
adding 100 ml of ortho-phosphoric acid. Plates were read in a
microplate reader (Spectra MR, Dynex, Richfield, MN).
Statistical analysis
Data were expressed as mean 6 standard deviation (SD) and
analyzed with ANOVA (a mixed-model, factorial ANOVA) by
means of SPSS 15.0 (SPSS Inc., Chicago, IL). Tukey Test was
used to evaluate significant differences between groups. To assess
the effect of pGSN levels and other independent variables on
burn-derived complications and mortality, Logistic regressions
were used as odds ratios (ORs) with 95% CI adjusting for the
pGSN level, burn size, age, gender and inhalation injury. A P
value of 0.05 or less was considered to indicate statistical
significance.
Results
Demographics
95 patients with burn injury were included in the present study.
The patients’ demography was illustrated in Table 2. The test for
homogeneity of variance was considered and the ANOVA
assumption was met. The omnibus ANOVA was also found
significant. There was no significant difference in age and gender
among the patients with different burn sizes. However, there were
significant differences in burn area between Group II and Group I
(P,0.01). The MODS group had markedly larger burn area
compared with the non-MODS group (P,0.01). Similarly, burn
area in the non-survivors was much larger than that in the
survivors (P,0.01). Both the length of hospital stay and the
number of operations divided by the burn size were longest/
largest in Group III, followed by Group II (P,0.01). Group III
had significantly more patients with ventilator assistance require-
ments compared with the other two groups (P,0.01).
Figure 2. Comparison of pGSN levels in burned patients with
or without MODS. Depressed pGSN levels (Fig. 2A) in burned patients
were detected in comparison to normal controls, and there were
obvious differences among patients with different extent of burn injury.
pGSN levels (Fig. 2B) were much lower in patients with MODS than
those without MODS on PBD 3–21. Among patients with MODS, pGSN
levels in the survivors were obviously lower than those with non-
survivors on PBD 1–21 (Fig. 2C). **P,0.01, Group I vs. normal group, or
MODS group vs. non-MODS group, or non-survivors group vs. survivors
group;
##P,0.01, Group II vs. Group I;
{{P,0.01, Group III vs. Group II.
doi:10.1371/journal.pone.0025748.g002
Figure 3. The relationship between pGSN levels and SOFA
scores in patients with MODS. It was a comparision of the mean
plasma gelsolin levels in 28 patients with different SOFA scores. The
mean pGSN level in the .12 SOFA score group was 57.6627.7 mg/L,
which was significantly lower than those in other three groups (the 0–4
SOFA score group: 122.3680.3 mg/L; the 5–8 SOFA score group:
101.5652.7 mg/L; the 9–12 SOFA score group: 92.4647.5 mg/L, all
P,0.01).
doi:10.1371/journal.pone.0025748.g003
Gelsolin and MODS after Burns
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To investigate the changes in pGSN levels, the blood samples
were detected by ELISA kits for human at different time points
and in different groups after burns. As shown in Fig. 1, pGSN
levels were significantly decreased in burned patients during PBD
1–21 compared with normal controls (P,0.01), and the lowest
level of pGSN (45.2867.22 mg/L) appeared on PBD 7. As shown
in Fig. 2, there were significant differences in plasma levels of
gelsolin among various groups. The pGSN levels were significantly
lower in MODS patients than those without MODS during PBD
3–21 (P,0.01). Among patients with MODS, the pGSN levels in
the survivor group were markedly higher than those with fatal
outcome during PBD 1–21 (P,0.01). Among survivors the
decreased pGSN levels appeared to partly retaliate after day 21
(244.51651.95 mg/L), whereas pGSN levels remained low or
even diminished further in the non-survivors with MODS (PBD
14: 19.4664.98 mg/L and PBD 21: 15.6164.17 mg/L).
The pGSN levels also gradually decreased with an increase in
the mean SOFA score in MODS patients, as shown in Fig. 3.
Meanwhile, as the pGSN levels decreased, the incidence of septic
complication, as well as MODS, was remarkably increased.
Patients with lowest pGSN levels (less than 100 mg/L) showed the
highest rate of the development into MODS, and this correlation
was more significant among patients who developed into sepsis
and septic shock (Table 3).
Changes in protein levels of cytokines released by T cells
As shown in Fig. 4, decreased expression of IL-2 released by T cells
from burned patients was detected on PBD 1–21 in comparison to
normal controls (25.6368.95 pg/ml, P,0.01), and there were
significant differences among patients in Group I and Group III
(17.3665.28 pg/ml versus 11.9263.44 pg/ml; P,0.01). Protein
levels of IL-2 released by T cells were significantly lower in patients
with MODS than those without MODS on PBD 3–21 (P,0.05 or
P,0.01). Among patients with MODS, IL-2 levels in the survivors
were significantly higher than those with non-survivors on PBD 3–21
(P,0.01). As shown in Fig. 5A and 5B, levels of IL-4 produced by T
cells in response to phytohemagglutinin (PHA) increased markedly
after burn injury, whereas levels of IFN-c decreased markedly as
compared with normal control group(IL-4: 17.6465.20 pg/ml, IFN-
c: 984.406292.52 pg/ml, all P,0.05), and there were obvious
differences between group I and group III (IL-4: 62.49618.22 pg/ml
versus 91.54618.29 pg/ml, P,0.01; IFN-c: 522.776132.28 pg/ml
versus 452.30696.71 pg/ml, P,0.05), indicating that Th cells might
have shifted to Th2 cells. As shown in Fig. 5C–5F, the similar results
were found in non-MODS patients and the survival group as
compared with those with MODS and the non-MODS group on
PBD 3–21 (P,0.05 or P,0.01).
Independent predictors for the development of MODS or
fatal outcome
The related factors of prognosis were analyzed by using
multivariate logistic regression analysis. The results showed that
the pGSN level, burn size, age and inhalation injury were
independent predictors for the development of both MODS and
fatal outcome of burn patients (P,0. 05, Table 4). Gender showed
no independent association with MODS and mortality of patients
(P.0. 05, Table 4).
Discussion
Severe burn injury may induce a temporal shift in immune
reactivity that can lead to septic syndrome or even death. The
immune system responds to injury by a rapid production of early
and late proinflammatory cytokines, and also suppression of T cell
functions [28]. Despite significant advances in intensive care
technologies and high enthusiasm in the development of new
antibiotics, severe sepsis and MODS after major burns still claims
40%–50% mortality in many countries [23,29]. Therefore, it is of
great significance to further elucidate the pathogenetic mecha-
nisms, and to seek novel interventional strategies to prevent and
treat sepsis or MODS secondary to severe trauma or burns.
The actin cytoskeleton is an essential scaffold for integrating
membrane and intracellular functions. It is very dynamic and is
remodeled in response to a variety of signals. Gelsolin was first
identified as a cytoplasmic actin-regulatory protein essential for
cell locomotion and phagocytosis. When a circulating isoform was
subsequently discovered, its physiological significance was far from
clear. For over two decades, researchers have made concerted
effort to define the raison d’e ˆtre for actin-binding proteins in plasma,
which under normal circumstances does not contain detectable
actin. A straightforward hypothesis emerged suggesting that pGSN
scavenges actin which leaked into the circulation or interstitial
space from injured tissue in order to abort subsequent damage
instigated by extracellular actin filaments [30]. In the study
conducted by Lee and coworkers [16], depletion of pGSN in
animal models of sepsis occurred within 6 hours after a septic
challenge with either endotoxin (lipopolysaccharide) or a multiple
microbes challenge after cecal-ligation and puncture [16]. Several
clinical studies [17,21] have observed that a low gelsolin level after
an initial insult, such as injury or inflammation, reflected greater
severity of disease and poorer outcome. The depletion of pGSN
Table 3. The relationship between pGSN levels and the incidences of sepsis and MODS in burned patients.
Variable MODS
Sepsis
(n=55)
Septic
shock
(n=16)
Circulatory
system failure
(n=21)
Respiratory system
failure (n=17)
Kidney failure
(n=11)
Failure of other
systems (n=35)
Gelsolin levels, n (%)
Level I 11(52.4) 8(47.1) 5(45.5) 18(51.4) 29(52.7) 14(87.5)
Level II 7(33.3) 6(35.3) 5(45.5) 9(25.7) 19(34.5) 2(12.5)
Level III 3(14.3) 3(17.6) 1(9.0) 8(22.9) 7(12.8) 0(0)
Mean pGSN levels during PBD 1–21 were determined in MODS and septic patients.
Level I: , or=100 mg/L, Level II: 100–200 mg/L, Level III: . or=200 mg/L.
doi:10.1371/journal.pone.0025748.t003
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cytoskeleton, which occurs as part of cellular injury [31–33]. In
turn, depletion of gelsolin could allow the formation of actin
filaments, which would lead to further tissue injury and multiple
organ dysfunction [4,30,34–38].
Accordingly, the degree of pGSN depletion might reflect the
extent of tissue injury leading to significant exposure of actin to the
extracellular space after major burns. In the current study, a
decreased level of pGSN from burned patients was also observed
on PBD 1–21 compared with normal controls, and there were
obvious differences among patients with different burn sizes. This
finding was consistent with the result of a previous report in an
animal model, showing a significant reduction in circulating
gelsolin levels within the first 2 hours of injury, with the decrease
persisting for at least 6 days postburn in burned rats [39]. The
diminution in pGSN levels after acute burn injury may reflect the
leakage of gelsolin, as well as other plasma proteins, across the
microvasculature at the site of the burn and in other microvascular
beds [40], and it enhanced clearance of gelsolin-actin complexes
by the liver [12]. The higher rates of loss of pGSN relative to total
plasma proteins at the later time points suggest that pGSN is
selectively removed from the circulation, that it is not recycled
once it leaked out of the vasculature, or that it is not replenished by
de novo synthesis. As we know, pGSN is synthesized primarily in
skeletal muscle [11], and burn injury promotes skeletal muscle
degradation [41]. It is unlikely that the reduction in circulating
gelsolin levels is due to expansion of the intravascular fluid
compartment by the infusion of crystalloid resuscitation fluids.
This notion is supported by the observations that pGSN
concentrations remained significantly reduced even when normal-
ized to circulating plasma protein levels, and the hematocrit of
burn injured patients was never less than that of the control group,
as one would expect had hemodilution been present. Irrespective
of how circulating gelsolin is decreased during burn injury, the
absolute reduction in the amount of pGSN would limit its
protective effects against inflammation for a prolonged period.
Based on our findings, it was indicated that a burn injury
involving larger than 50% TBSA caused remarkably prolonged
length of stay in hospital, significant increase in number of
operations, and incidence of infection and MODS. Indeed, several
investigators also found that low pGSN levels were associated with
poor outcome in trauma [19] and critically ill surgical patients
[18,42]. The present study focused on the clinical implications of
pGSN levels obtained after admission. We demonstrated that,
although almost all the patients had decreased gelsolin levels after
extensive burn injuries, the lowest levels were associated with less
SOFA score and more complicated disease courses (e.g. sepsis or
septic shock). We alao found that the pGSN levels were lower in
patients with MODS than those without MODS and healthy
control individuals. Moreover, as the pGSN levels decreased, the
incidences of septic complication as well as MODS remarkably
increased. It seemed that the pGSN level might correlate with
occurrence of severe sepsis and MODS, and it did significantly
differ between surviving and nonsurviving patients with MODS.
In the current study, recovery of pGSN levels was observed late in
the course in survivors but not in non-survivors with MODS, thus
gelsolin levels might be a discriminative index in this context. On
one hand, the gelsolin level provides an earlier or more reliable
marker of the development of MODS than do conventional
parameters; on the other hand, there are biologically plausible
reasons to implicate gelsolin as a potential physiological mediator
in the evolution of poor outcome in burn patients.
Severe thermal injury induces detrimental changes in immune
function, often rendering the host highly susceptible to develop-
Figure 4. ELISA analysis of IL-2 levels released by T cells.
Decreased expression of IL-2 released by T cells from burned patients
was noted on PBD 1–21 in comparison to normal controls, and there
were obvious differences among patients in Group I and Group III
(Fig. 3A). Protein levels of IL-2 of T cells were significantly lower in
patients with MODS than those without MODS on PBD 3–21 (Fig. 3B).
Among patients with MODS, IL-2 levels in the survivors were obviously
higher than those with non-survivors on PBD 3–21 (Fig. 3C). *P,0.05,
**P,0.01, Group I vs. normal group, or MODS group vs. non-MODS
group, or non-survivors group vs. survivors group;
##P,0.01, Group III
vs. Group I.
doi:10.1371/journal.pone.0025748.g004
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PLoS ONE | www.plosone.org 6 November 2011 | Volume 6 | Issue 11 | e25748Figure 5. ELISA analysis of of IL-4 and IFN-c released by T cells. Levels of IL-4 produced by T cells response to PHA increased markedly after
burn injury, whereas levels of IFN-c decreased markedly as compared with normal control group, and there were obvious differences between group
I and group III, indicating that Th cells might have shifted to Th2 cells (as shown in Fig. 4A and 4B). The similar results were obtained in non-MODS
patients and the survival group as compared with those with MODS and the non-survival group on PBD 3–21 (as shown in Fig. 4C,4F). *P,0.01,
**P,0.01, Group I vs. normal group, or MODS group vs. non-MODS group, or non-survivors group vs. survivors group;
#P,0.01,
##P,0.01, Group III
vs. Group I.
doi:10.1371/journal.pone.0025748.g005
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anisms have been proposed to explain infection-induced immu-
nosuppression, including an imbalance in the cellular helper T cell
(Th1/Th2) or cytokine profile, induction of anergy, depletion of
effector cells and most recently the activation of CD4
+CD25
+
Tregs [43]. In our previous experiments [44–46], significant
proliferation of splenic T cells and IL-2 as well as IL-2Ra
expression on T cells were simultaneously suppressed to certain
extent after burns. Current dogma has expanded to now
accommodate the convincing observations that pGSN can bind
a variety of potentially inflammatory moieties, and can thereby
modulate the exuberance of the host response to sepsis, malaria,
burns, trauma, and other commonly encountered clinical
conditions [34,36,39,42]. It is well established that major burn
injury per se can trigger both excessive inflammation and
suppressed adaptive immunity. Actin exposed at the site of an
overwhelming injury may act as a sink to exhaust the supply of
pGSN, in turn allowing redundant inflammatory cascades
unfettered opportunity to wreak havoc upon multiple organ
systems. After a phase of excessive immune activation, a marked
apoptosis-induced depletion of lymphocytes and a nonspecific
anergy of immune function subsequent to severe insults might be
responsible for the increased susceptibility of the host to
subsequent septic complications. Similarly, our results in this
study showed that the levels of IL-4 produced by T cells increased
markedly after burn injury, whereas levels of IL-2 as well as IFN-c
decreased markedly, indicating that Th cells might have shifted to
Th2 cells.
These observations of 95 patients with burn injuries of different
extent confirmed the strong correlation between pGSN levels and
such important clinical complications as the development of
MODS and fatal outcome. Still unsettled issues concern the
particular or incremental utility of gelsolin levels as timely
prognostic indicators, the generalization of these findings to
diverse clinical situations [21], and the biological consequences
resulting from hypogelsolinemia. Rothenbach et al [13] found that
intravenous infusion of recombinant human gelsolin completely
prevented an increase in pulmonary microvascular permeability in
burn injured rats. This study provides additional evidence to
support the notion that circulating gelsolin has an important
preventive effect on the pathophysiology of systemic inflammatory
states after severe burns. The potential therapeutic benefits of
infusions of recombinant human pGSN for patients in whom
sepsis and multiorgan dysfunction commonly follows a serious
insult have not yet been investigated. Nevertheless, it was evident
that gelsolin repletion to physiological levels between the time of
the initial insult and subsequent complications in patients
identified by marked hypogelsolinemia as being at substantial risk
for delayed multiorgan dysfunction could provide a directed and
effective therapeutic intervention in critically ill patients.
Conclusions
In conclusion, pGSN may be a valuable marker for severe
complications in patients suffering from major burns. Extensive
burn injury could result in significantly decreased pGSN levels,
which appears to be associated with the development of MODS
and fatal outcome secondary to acute insults. It also suggested that
the potential therapeutic benefits of infusions of recombinant
human pGSN might be important to the Th1/Th2 cytokine
balance in patients after extensive burns. The prognostic role of
pGSN in a critical illness requires further investigation in a large
cohort.
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